OBJECTIVE:Education and self-management training assist patients with bipolar disorder to take control of their condition and to reduce disability, but the timeliness and availability of the education are important. A free Web-based bipolar education program has been recently developed to provide accessible evidence-based information for patients, carers and health professionals. The present paper describes the nine-module program, reports usage data and user profiles, and overviews the aims and methodology of a randomized controlled trial to measure its impact. METHODS: Customized Web reports were developed to measure usage of the Web-based program, and to profile its users on a month-by-month basis. Data on the percentage of completers of each module were also collected. A randomized controlled trial evaluating the program in people with newly diagnosed bipolar disorder was also commenced. RESULTS: More than 8,000 visitors used the online program in its first 6 months. Users were predominantly female, of a broad cross-section of ages, 43.5% with bipolar disorder, and with the remainder describing themselves as health professionals, carers/family/friends of a person with bipolar disorder or members of the general public. The majority (76%) completed the sessions they commenced. CONCLUSIONS: The Web-based education program is attracting a steady stream of users and is exhibiting good completion rates. This preliminary support for the program's utility requires validation from our randomized controlled trial before definite conclusions can be drawn.
RCT Entities:
OBJECTIVE: Education and self-management training assist patients with bipolar disorder to take control of their condition and to reduce disability, but the timeliness and availability of the education are important. A free Web-based bipolar education program has been recently developed to provide accessible evidence-based information for patients, carers and health professionals. The present paper describes the nine-module program, reports usage data and user profiles, and overviews the aims and methodology of a randomized controlled trial to measure its impact. METHODS: Customized Web reports were developed to measure usage of the Web-based program, and to profile its users on a month-by-month basis. Data on the percentage of completers of each module were also collected. A randomized controlled trial evaluating the program in people with newly diagnosed bipolar disorder was also commenced. RESULTS: More than 8,000 visitors used the online program in its first 6 months. Users were predominantly female, of a broad cross-section of ages, 43.5% with bipolar disorder, and with the remainder describing themselves as health professionals, carers/family/friends of a person with bipolar disorder or members of the general public. The majority (76%) completed the sessions they commenced. CONCLUSIONS: The Web-based education program is attracting a steady stream of users and is exhibiting good completion rates. This preliminary support for the program's utility requires validation from our randomized controlled trial before definite conclusions can be drawn.
Authors: Karen L Fortuna; Anjana Muralidharan; Carly M Goldstein; Maria Venegas; Joseph E Glass; Jessica M Brooks Journal: J Technol Behav Sci Date: 2020-04-27
Authors: Judith G Proudfoot; Amisha Jayawant; Alexis E Whitton; Gordon Parker; Vijaya Manicavasagar; Meg Smith; Jennifer Nicholas Journal: BMC Psychiatry Date: 2012-11-09 Impact factor: 3.630
Authors: Jennifer Nicholas; Judith Proudfoot; Gordon Parker; Inika Gillis; Rowan Burckhardt; Vijaya Manicavasagar; Meg Smith Journal: J Med Internet Res Date: 2010-12-19 Impact factor: 5.428
Authors: Charles L Bowden; Richard Priesmeyer; Mauricio Tohen; Vivek Singh; Joseph R Calabrese; Terry Ketter; Andrew Nierenberg; Michael E Thase; Gregg Siegel; Leslie H Siegel; Jim Mintz; Rif S El-Mallakh; Susan L McElroy; Melissa Martinez Journal: Psychopharmacol Bull Date: 2021-03-16
Authors: Lesley Berk; Michael Berk; Seetal Dodd; Claire Kelly; Stefan Cvetkovski; Anthony Francis Jorm Journal: BMC Med Date: 2013-07-11 Impact factor: 8.775